Trevi Therapeutics Balance Sheet
NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Trevi Therapeutics financial position
At the end of fiscal 2025, Trevi Therapeutics reported total assets of $193.4 million, up 74.4% from a year earlier against total liabilities of $10.2 million. Shareholders' equity stood at $183.2 million, or 94.7% of assets. The company held $18.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 19.66, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Trevi Therapeutics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 18.91M | 34.10M | 32.40M | 12.59M | 36.83M | 45.00M | 57.31M | 7.20M |
| Short-Term Investments | 169.35M | 73.53M | 50.57M | 107.92M | — | — | — | — |
| Total Current Assets | 191.66M | 109.43M | 87.55M | 122.62M | 37.96M | 46.27M | 59.55M | 8.82M |
| Property, Plant & Equipment | 178.00K | 157.00K | 216.00K | 170.00K | 53.00K | 103.00K | 118.00K | 149.00K |
| Total Assets | 193.44M | 110.90M | 89.40M | 123.02M | 38.48M | 47.13M | 60.00M | 10.53M |
| Accounts Payable | 3.91M | 3.41M | 1.81M | 2.86M | 2.85M | 2.02M | 1.60M | 603.00K |
| Total Current Liabilities | 9.75M | 10.51M | 5.82M | 13.40M | 12.72M | 5.55M | 5.20M | 2.68M |
| Total Liabilities | 10.20M | 11.26M | 6.86M | 15.56M | 21.40M | 19.85M | 5.46M | 120.02M |
| Shareholders' Equity | 183.24M | 99.64M | 82.55M | 107.46M | 17.07M | 27.28M | 54.55M | -109.49M |
| Retained Earnings | -329.80M | -287.05M | -239.13M | -210.07M | -180.92M | -146.98M | -114.22M | -109.50M |
| Net Cash (Debt) | 188.26M | 107.62M | 82.97M | 120.51M | 36.83M | 45.00M | 57.31M | 7.20M |
| Shares Outstanding | 128.31M | 93.60M | 68.28M | 59.94M | 28.51M | 18.55M | 17.83M | 438.60K |
This table shows 8 annual periods of Trevi Therapeutics's balance sheet, from FY 2025 back to FY 2018, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow TRVI's reporting calendar. What is a balance sheet?